Quest Diagnostics, Inc. (DGX) Tops Q3 EPS by 7c; Guides FY11 EPS Above Views
Tweet
Share
E-mailGet Alerts DGX Hot Sheet
Price: $234.40 -0.69%
Financial Fact:
Equity earnings in unconsolidated joint ventures: 11M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Equity earnings in unconsolidated joint ventures: 11M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Quest Diagnostics, Inc. (NYSE: DGX) reported Q3 EPS of $1.18, $0.07 better than the analyst estimate of $1.11. Revenue for the quarter came in at $1.9 billion versus the consensus estimate of $1.89 billion.
Quest Diagnostics, Inc. sees FY2011 EPS of $4.30-$4.35, versus the consensus of $4.21. Sees revenues growing 1.5%, unchanged from previous guidance
Quest Diagnostics, Inc. sees FY2011 EPS of $4.30-$4.35, versus the consensus of $4.21. Sees revenues growing 1.5%, unchanged from previous guidance
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
- Quest Diagnostics (DGX) Declares $0.86 Quarterly Dividend; 1.4% Yield
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
